Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
This study is currently recruiting participants.
Study NCT00436618 Information provided by National Cancer Institute (NCI)
First Received: February 15, 2007 Last Updated: October 29, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lymphoma
Lymphoproliferative Disorder
Small Intestine Cancer
Additional conditions recognized in this trial
Disease
Duodenal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Lymphoproliferative Disorders
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Ileal Diseases
Immune System Diseases
Immunoproliferative Disorders
Intestinal Diseases
Jejunal Diseases
Lymphatic Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Pathologic Processes
Interventions listed in this trial
everolimus
laboratory biomarker analysis
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Mayo Clinic
National Cancer Institute (NCI)
Back to top of Main Content
